AFP and liver cancer: Although regular ultrasound and serum alpha-fetoprotein (AFP) levels are monitored in high-risk populations, it is reported that 70% of HCC patients are diagnosed in the intermediate Barcelona Clinic Liver Cancer (BCLC) stage or advanced (BCLC stage C) stage (1).